Multiple Sclerosis: Rising Prevalence, Improving Survival and the Fight for Equitable Care
Multiple sclerosis (MS) is becoming increasingly prevalent in England, more than doubling between 2000 and 2020, with an annual increase of 6%. However, a new study from UCL and Imperial College London reveals a hopeful trend: survival rates for those diagnosed with MS are also improving. As of 2023, an estimated 190,000 people in England are living with MS.
The Disparity in Diagnosis and Outcomes
Whereas advancements in treatments and earlier diagnosis are contributing to longer lifespans for people with MS, significant inequalities persist. The study highlights a concerning correlation between deprivation and mortality rates. Individuals in more deprived areas face a higher risk of death from MS, while the prevalence of the condition is highest in less deprived areas.
Researchers suggest this disparity stems from a combination of factors. People in deprived areas may be less likely to receive a timely diagnosis, have limited access to care, and experience delays in treatment. They are also more likely to have co-existing health conditions and engage in lifestyle factors – such as smoking and obesity – that can worsen MS outcomes.
The Role of Early Diagnosis and Targeted Support
Professor Raffaele Palladino (Imperial College London and University of Naples Federico II), the study’s first author, emphasizes the need for improved early diagnosis, particularly within socioeconomically disadvantaged groups. Addressing barriers to diagnosis and care is crucial for reducing inequalities.
Dr. Catherine Godbold, Senior Research Communications Manager at the MS Society, echoes this sentiment, stating, “Exploring the role of deprivation in MS outcomes is important research. It’s encouraging to see evidence showing improvements in life expectancy for people with MS. But we need to see more consistent access to diagnosis, treatment, and support for people to manage their symptoms so that everyone with MS, whatever their circumstances or where they live, can live well.”
Stem Cell Research Offers New Hope
Alongside improvements in care, ongoing research is exploring innovative treatments for MS. A recent study led by Cambridge researchers demonstrates that neural stem cell grafts can restore myelin – the protective sheath around nerve fibres – in mouse models of MS. This offers a promising avenue for treating chronic demyelinating disorders, particularly progressive MS, where the body’s ability to repair myelin diminishes over time.
While current therapies primarily focus on managing symptoms, stem cell-based therapies aim to address the underlying damage and neurodegeneration caused by MS. This research underscores the critical need for a deeper understanding of MS progression and the potential of stem cell technologies.
Cognition and the Invisible Symptoms of MS
MS symptoms vary significantly from person to person, and many are invisible. Recent research highlights the importance of addressing cognitive symptoms, which have historically been overlooked and neglected, leaving individuals to struggle without adequate support.
The Impact of Gender on MS
Women are two and a half times more likely to develop MS than men, and the condition can have different implications for women’s health. Increased research focusing on the unique aspects of MS in women is essential to improve diagnosis and treatment strategies.
Frequently Asked Questions
- What is MS?
- MS is a neurological condition where the immune system attacks the central nervous system.
- What are some early signs of MS?
- Common early signs include tingling, numbness, limb weakness, and problems with vision.
- Is MS curable?
- Currently, there is no cure for MS, but treatments can help manage symptoms and slow disease progression.
- How does deprivation affect MS outcomes?
- People in deprived areas may face barriers to diagnosis, care, and healthy lifestyle choices, leading to poorer outcomes.
Want to learn more? Explore additional resources on the MS Society website.
Share your thoughts and experiences with MS in the comments below. Let’s continue the conversation and raise awareness about this complex condition.
